Breaks Categories: News

MondayDec 16, 2019 10:58 am

NetworkNewsBreaks – Siyata Mobile Inc. (TSX.V: SIM) (OTCQX: SYATF) Receives Purchase Orders Totaling Over $900K for 4G/LTE Push-to-Talk Over Cellular Devices

Siyata Mobile (TSX.V: SIM) (OTCQX: SYATF), a developer and provider of cellular communications solutions for enterprise workers and first responders, today announced its receipt of two purchase orders totaling over $900,000 for its connected vehicle and Push-to-talk over Cellular (“PoC”) solutions. According to the update, the company received one order from a new customer for over $600,000 to equip their connected vehicles with Siyata’s 4G/LTE in-vehicle solutions, as well as an additional $300,000 order from first responder contracts, increasing the customer’s total purchase order to over $3.25M since delivery commenced in 2018. “We continue to win new business and see…

Continue Reading

MondayDec 16, 2019 10:29 am

NetworkNewsBreaks – MCTC Holdings, Inc. (MCTC) Releases CEO Shareholder Letter, Strategic Direction for 2020

MCTC Holdings (OTC: MCTC) today provided a letter to its shareholders to recap 2019 and provide an overview of the company’s plans moving into 2020. Among the topics covered, the letter discussed the company’s reorganization with a new management team led by Arman Tabatabaei, as well as installation of an experienced board of directors. The letter also covered the company’s current strategic direction to re-position in the cannabinoid sciences arena. “It is our team's strong belief that one of the most underserved submarkets of the hemp and cannabis marketplaces relates to the delivery of hemp extracts and cannabinoids to the…

Continue Reading

MondayDec 16, 2019 9:58 am

NetworkNewsBreaks – Grapefruit Boulevard Investments Inc. (IGNG) Announces FINRA Filing to Change Corporate Name and Stock Ticker Symbol

Grapefruit Boulevard Investments, a Los Angeles based California corporation and wholly owned subsidiary of Imaging3, Inc. (OTCQB: IGNG), (collectively “Grapefruit”), this morning announced that, as of today, December 16, 2019, it has filed with the Financial Industry Regulatory Authority (“FINRA”) to change the company’s corporate name to Grapefruit USA, Inc., and stock ticker symbol to “GUSA,” “GPRE,” “GPFT” or such other symbol as FINRA and Grapefruit may agree. “Now that Grapefruit’s audit is complete and IGNG’s Super 8K has been filed, we are pleased to take this final step to formalize our transition from a development stage medical device company…

Continue Reading

FridayDec 13, 2019 11:01 am

NetworkNewsBreaks – City View Green Holdings Inc. (CSE: CVGR) (OTC: CVGRF) Amends Private Placement, Warrant Expiry Date

City View Green Holdings (CSE: CVGR) (OTC: CVGRF) today announced that it has repriced its non-brokered private placement, previously disclosed on October 4, 2019. According to the update, the remaining $1,400,000 is proposed to be sold at a price of $0.125/unit. Each unit will be comprised of one common share in the capital of the company and one common share purchase warrant of the company, with each warrant exercisable into one common share in the capital of the company at an exercise price of $0.20/share for a period of three years from the date of issuance of the warrants. City…

Continue Reading

FridayDec 13, 2019 10:28 am

NetworkNewsBreaks – MustGrow Biologics Corp. (CSE: MGRO) (OTC: MGROF) Releases Crop Protection Product Pipeline and Work Schedule

MustGrow Biologics (CSE: MGRO) (OTC: MGROF), an agricultural biotech company developing and commercializing a portfolio of natural, science-based biological crop protection products, today announced its biologic crop protection product pipeline and associated work schedule. The company’s signature mustard-derived bio-pesticide product in ‘granule format’ is EPA-approved for use in fruits, vegetables, nuts, turf and ornamentals. In addition, its Liquid Formulation has achieved 100% control of hard-to-kill soil borne diseases such as Botrytis and Fusarium. MustGrow’s product pipeline table released with the update outlines the advancement progress of its Liquid Formulation in applicable crop protection categories. To view the full press release,…

Continue Reading

FridayDec 13, 2019 10:07 am

NetworkNewsBreaks – Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI) Receives Health Canada Approval for Licensing of 16 Additional Cultivation Rooms Under Cannabis Regulations

Organigram Holdings (NASDAQ: OGI) (TSX: OGI), the parent company of Organigram Inc. (the “company” or “Organigram”), a leading licensed producer of cannabis, today announced the company’s receipt of Health Canada’s approval for the licensing of 16 additional cultivation rooms under the Cannabis Regulations. According to the update, the expanded license was effective as of December 12, 2019, and the new cultivation rooms represent approximately 13,000 kg/yr1 of increased target cultivation capacity. “This is a dynamic time for Organigram and the industry as a whole. Cannabis 2.0 – the legalization of adult use recreational cannabis edibles, vape products, extracts and topicals…

Continue Reading

ThursdayDec 12, 2019 2:25 pm

NetworkNewsBreaks – No Borders Inc. (NBDR) Expands Strategic Advisory Board with Addition of Finance Executive Stefan Lloyd

No Borders (OTC: NBDR) today announced its addition of Stefan Lloyd as its newest member of the Strategic Advisory Board. Stefan, a globally renowned finance professional, sits on the Advisory Board of Ekap Aif, a Swedish venture capital firm as well as the Swedish American Chamber of Commerce in Texas and previously at the Institute for Innovation and Entrepreneurship at the University of Texas at Dallas. Stefan has dual nationalities (Swedish/British) and, prior to joining the No Borders Strategic Advisory Board, most of his career in finance has ranged from M&A at UBS in the UK to co-founding and co-managing…

Continue Reading

ThursdayDec 12, 2019 1:31 pm

NetworkNewsBreaks – Tilray, Inc. (NASDAQ: TLRY) Receives Second GMP Certification for Cantanhede, Portugal Facility Allowing International Export of Finished Medical Cannabis Products

Tilray (NASDAQ: TLRY), a global pioneer in cannabis research, cultivation, production and distribution, on Wednesday announced its wholly-owned subsidiary Tilray Portugal, Unipessoal Lda. (“Tilray Portugal”) has received its Good Manufacturing Practice (“GMP”) certification in accordance with European Union standards, for its manufacturing facility in Cantanhede, Portugal. According to the update, Infarmed, the Portuguese National Authority of Medicines and Health Products, issued the GMP certification. This is Tilray Portugal’s second GMP certification, which allows the facility to manufacture and export GMP-certified finished medical cannabis products, including dried flower and oils, from Portugal to international markets with legal medical cannabis regulations. “We…

Continue Reading

ThursdayDec 12, 2019 1:27 pm

NetworkNewsBreaks – 1933 Industries Inc. (CSE: TGIF) (OTCQX: TGIFF) Enters Strategic Partnership with Premium Cannabis-Infused Food Brand Pantry for Production of Edibles in Nevada

1933 Industries (CSE: TGIF) (OTCQX: TGIFF), a vertically integrated cannabis consumer packaged goods company, recently announced the execution of a two-year licensing agreement between its subsidiary, Alternative Medicine Association LC ("AMA") and Los Angeles-based The Pantry Company Inc. ("Pantry"). Per the update, the agreement is for the production of edible products in Nevada and adds a new vertical to the company's portfolio of leading cannabis brands. "We are excited to expand our product offering in Nevada with a gourmet line that will set the standard for excellence in edibles,” 1933 Industries CEO Chris Rebentisch said in the news release. “The…

Continue Reading

ThursdayDec 12, 2019 12:48 pm

NetworkNewsBreaks – CURE Pharmaceutical (CURR) Appoints Canopy Rivers’ (TSX: RIV) (OTC: CNPOF) Chairman, John K. Bell, to Board of Directors

CURE Pharmaceutical (OTCQB: CURR), an innovative drug delivery and development company, recently announced the appointment of John K. Bell, FCA, FCPA, ICD.D to its board of directors. Bell brings more than 40 years of experience to Cure Pharmaceutical, most recently serving as chairman of the Canopy Rivers Inc. (TSX: RIV) (OTC: CNPOF) board of directors. “John’s unparalleled depth and breadth of expertise makes him an invaluable asset to our growth strategy,” CURE Pharmaceutical CEO Rob Davidson said in the news release. “His impressive array of experience supports every aspect of our business, including pharmaceutical, manufacturing, financial and cannabis.” To view…

Continue Reading